EPFL
Client-side scanning is like bugs in our pockets
Politics
EPFL
Encryption provides a solution to security risks, but its flipside is that it can hinder law enforcement investigations. A new technology called client-side scanning (CSS) would enable targeted information to be revealed through on-device analysis, without weakening encryption or providing decryption keys. However, an international group of experts, including EPFL, has now released a report raising the alert, arguing that CSS neither ensures crime prevention nor prevents unwarranted surveillance.
A machine designs new Swiss Alpine architecture at the Seoul Biennale
Research
EPFL
The Artificial Swissness exhibit – a larger than life-sized “design brain” developed by EPFL’s Media x Design Lab (LDM) – is currently on display at the Seoul Biennale for Architecture and Urbanism, which runs until 31 October 2021. This high-tech machine can generate a virtually infinite number of architectural images of Swiss Alpine cabins.
New nanowire architectures boost computers' processing power
Research
EPFL
Valerio Piazza is creating new 3D architectures built from an inventive form of nanowire. His research aims to push the boundaries of miniaturization and pave the way to more powerful electronic devices. He has just won the 2020 Piaget Scientific Award, whose prize money will fund his work at EPFL for a year.
Social media and AI can measure the aesthetic quality of landscapes
Research
EPFL
To measure an ecosystem’s beauty and the well-being it produces for people can help inform public environmental policy. Scientists at EPFL and Wageningen University in the Netherlands have developed a novel modeling approach for ecosystem assessments based on deep learning and millions of Flickr photos.
New proteins enable scientists to control cell activities
Research
EPFL
EPFL scientists have developed new controlled proteins and used to switch cellular activities on and off like a light bulb.
Scientists discover a highly potent antibody against SARS-CoV-2
Research
EPFL
Scientists at Lausanne University Hospital (CHUV) and EPFL have discovered a highly potent monoclonal antibody that targets the SARS-CoV-2 spike protein and is effective at neutralizing all variants of concern identified to date, including the delta variant. Their findings are published in the prestigious journal Cell Reports.
Page 80 of 102